AbClon Inc.
KOSDAQTotal Valuation
AbClon Inc. carries a market capitalization of 460.28B, placing it among publicly traded companies globally. Its enterprise value stands at 1.04T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 460.28B |
| Enterprise Value | 1.04T |
Valuation Ratios
The price-to-sales ratio is 225.89, and the price-to-book ratio stands at -12.79.
| PE Ratio | N/A |
| PS Ratio | 225.89 |
| PB Ratio | -12.79 |
| P/TBV Ratio | 18.60 |
| P/FCF Ratio | -102.87 |
| P/OCF Ratio | -100.88 |
Enterprise Valuation
| EV / Sales | 218.62 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
AbClon Inc. maintains a current ratio of 4.89, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.74, indicating elevated leverage, while an interest coverage ratio of -50.96 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.89 |
| Quick Ratio | 4.73 |
| Debt / Equity | 12.74 |
| Debt / EBITDA | -0.50 |
| Interest Coverage | -50.96 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -29.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 20.94 |
Stock Price Statistics
AbClon Inc.'s stock has gained approximately 108.10811% over the past 52 weeks. The 50-day moving average sits at 36,434.00, while the 200-day moving average is 43,036.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 108.10811% |
| 50-Day Moving Average | 36,434.00 |
| 200-Day Moving Average | 43,036.40 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, AbClon Inc. generated 4.74B in revenue and converted that into -14.83B in net income, yielding earnings per share of -786.25. EBITDA reached -14.95B, while operating income came in at -14.95B.
| Revenue | 4.74B |
| Gross Profit | 1.28B |
| Operating Income | -14.95B |
| Pretax Income | -14.84B |
| Net Income | -14.83B |
| EBITDA | -14.95B |
| EBIT | -14.95B |
| Earnings Per Share (EPS) | -786.25 |
Balance Sheet
AbClon Inc. holds 42.11B in cash and equivalents against 7.42B in total debt, resulting in a net debt position of -29.11B. Total book value stands at -83.61B, with working capital of 34.61B providing operational flexibility.
| Cash & Cash Equivalents | 42.11B |
| Total Debt | 7.42B |
| Net Debt | -29.11B |
| Equity (Book Value) | -83.61B |
| Book Value Per Share | -4,431.66 |
| Working Capital | 34.61B |
Cash Flow
AbClon Inc. produced -10.60B in operating cash flow over the past twelve months. After subtracting -204.19M in capital expenditures, free cash flow totaled -10.81B - equivalent to -572.85 per share.
| Operating Cash Flow | -10.60B |
| Capital Expenditures | -204.19M |
| Free Cash Flow | -10.81B |
| FCF Per Share | -572.85 |
Margins
AbClon Inc. operates with a gross margin of 26.95, reflecting its pricing power and cost economics. The operating margin of -315.63 and net profit margin of -313.23 provide insight into operational efficiency.
| Gross Margin | 26.95 |
| Operating Margin | -315.63 |
| Pretax Margin | -313.28 |
| Profit Margin | -313.23 |
| EBITDA Margin | -315.63 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4.50 |
| FCF Yield | -0.97 |
Stock Splits
AbClon Inc.'s most recent stock split took place on July 16, 2020 with a 1:2 split ratio.
| Last Split Date | 7/16/2020 |
| Split Ratio | 1:2 |
Scores
AbClon Inc. posts an Altman Z-Score of 61.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 61.21 |